These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 20460057)

  • 1. [Construction of hepatitis C virus-NS3 Th1 plasmid vaccine based on MHC class II-associated invariant chain peptide substitution].
    Gao M; Wang HP; Lu Y; Zhou Y; Wang YN; Zhan LS; Wang QL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):309-10. PubMed ID: 20460057
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target HCV NS3 CD4+ Th1 epitope to major histocompatibility complex class II pathway.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Biotechnol Lett; 2006 Jan; 28(1):3-8. PubMed ID: 16369867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
    van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
    Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine.
    Memarnejadian A; Roohvand F
    Cell Immunol; 2010; 261(2):93-8. PubMed ID: 20056196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
    Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
    Gene Ther; 2004 Mar; 11(6):522-33. PubMed ID: 14999224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
    Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
    Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
    Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response.
    Toda M; Kasai M; Hosokawa H; Nakano N; Taniguchi Y; Inouye S; Kaminogawa S; Takemori T; Sakaguchi M
    Eur J Immunol; 2002 Jun; 32(6):1631-9. PubMed ID: 12115646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II.
    Naujokas MF; Southwood S; Mathies SJ; Appella E; Sette A; Miller J
    Cell Immunol; 1998 Aug; 188(1):49-54. PubMed ID: 9743557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.
    Farr A; DeRoos PC; Eastman S; Rudensky AY
    Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.
    Zhang T; Maekawa Y; Yasutomo K; Ishikawa H; Fawzy Nashed B; Dainichi T; Hisaeda H; Sakai T; Kasai M; Mizuochi T; Asao T; Katunuma N; Himeno K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):693-701. PubMed ID: 11027533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice deficient in invariant-chain and MHC class II exhibit a normal mature B2 cell compartment.
    Maehr R; Kraus M; Ploegh HL
    Eur J Immunol; 2004 Aug; 34(8):2230-6. PubMed ID: 15259020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype and function of CD4+ T cells in mice lacking invariant chain.
    Wong P; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2133-42. PubMed ID: 8690902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BALB/c invariant chain mutant mice display relatively efficient maturation of CD4+ T cells in the periphery and secondary proliferative responses elicited upon peptide challenge.
    Kenty G; Bikoff EK
    J Immunol; 1999 Jul; 163(1):232-41. PubMed ID: 10384121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.